UnitedHealth Group Incorporated Stock Price and Value Analysis

UnitedHealth Group Incorporated (NYSE:UNH) with its current price, filing history and research links below. Our cash flow valuation does not fit this type of company, so there is no fair price.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Inside the UNH Numbers

UNH Price
(UnitedHealth Group Incorporated stock price per share)
$330.48
[?] PE Ratio versus Sector 42% higher than other Financial Services stocks
[?] PE Ratio versus Industry 54% higher than other Insurance - Specialty stocks
[?] Dividend Yield 2.59% (tax impact)
Shares Shorted 13,963,759

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 13,963,759 shares shorted. With 893,451,026 shares available for purchase and an average trading volume over the past 10 trading days of 6,347,430, it would take at least 2.2 days for all of the short holders to cover their shorts.

Why This Page Shows No Fair Price

Trendshare's cash flow valuation is built for operating companies, which sell goods or services and keep what is left after paying for the equipment they need. It does not fit banks, insurers, real estate investment trusts (REITs) or funds. Their cash flows include deposits, loan repayments, insurance premiums and distributions the company must pay out, so free cash flow does not measure what the business earns for its owners. For that reason this page shows no fair price, safety price or price comparison for UnitedHealth Group Incorporated. The price and basic facts above come from market data, and the filing history below comes from the company's own SEC reports.

To judge a company like this, read its filings on SEC EDGAR. Our investment guide explains the measures that suit each kind of company.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 42% above the average for stocks in the Financial Services sector.

Its trailing P/E ratio is 54% above the average for stocks in the Insurance - Specialty industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $75,431 million in 2007 and $447,567 million in 2025, a compound annual growth rate of 10.4% over 18 years.

Revenue rose 11.8% from 2024 to 2025.

Our estimated free cash flow was $16,544 million in 2025, 3.7% of revenue. In 2007 the estimated margin was 6.6%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2007 75,431 5,006 6.6%
2008 81,186 3,407 4.2%
2009 87,138 4,825 5.5%
2010 94,155 5,453 5.8%
2011 101,862 6,099 6.0%
2012 110,618 6,246 5.6%
2013 122,489 5,979 4.9%
2014 130,474 6,882 5.3%
2015 157,107 8,435 5.4%
2016 184,840 8,362 4.5%
2017 201,159 11,973 6.0%
2018 226,247 13,939 6.2%
2019 242,155 16,579 6.8%
2020 257,141 20,191 7.9%
2021 287,597 20,211 7.0%
2022 324,162 23,918 7.4%
2023 371,622 26,515 7.1%
2024 400,278 21,366 5.3%
2025 447,567 16,544 3.7%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $24,365 million against total liabilities of $207,883 million, or 11.7% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 67.1% of total assets in 2025, compared with 62.8% in 2008, an increase of 4.4 percentage points.

Stockholders equity was $5,980 million in 2025, compared with $20,780 million in 2008, a fall of 71.2%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 9.7% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2008 55,815 7,426 35,035 20,780
2009 59,045 9,800 35,439 23,606
2010 63,063 9,123 37,238 25,825
2011 67,889 9,429 39,597 28,292
2012 80,885 8,406 47,586 31,178
2013 81,882 7,276 48,558 32,149
2014 86,300 7,495 52,540 32,454
2015 111,254 10,923 75,793 -105
2016 122,810 10,430 82,621 -97
2017 139,058 11,981 87,036 2,057
2018 152,221 10,866 95,994 2,623
2019 173,889 10,985 111,727 2,820
2020 197,289 16,921 126,750 2,837
2021 212,206 21,375 135,727 3,285
2022 245,705 23,365 159,358 3,678
2023 273,720 25,427 174,801 5,665
2024 298,278 25,312 195,687 5,610
2025 309,581 24,365 207,883 5,980

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 731766.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-19

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

This analysis covers US companies that file 10-K annual reports. No fair price is shown for this company, because free cash flow does not describe banks, insurers, real estate investment trusts and funds. In the balance sheet and revenue tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: UNH annual reports (10-K) on SEC EDGAR. Our editorial standards explain how Trendshare handles its sources and corrections.

Questions to Answer Before You Invest in UNH

Does UnitedHealth Group Incorporated have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.